Michael Foote, MD

Michael Foote, MD

Michael Foote, MD

Michael Foote, MD, is a medical oncologist at Memorial Sloan Kettering Cancer Center

Articles by Michael Foote, MD
Can Aspirin Prevent Recurrence in Early-Stage Colorectal Cancer? Insights from the ALASCCA Study
Michael Foote, MDColorectal Cancer | April 7, 2025
Low-dose aspirin halved recurrence in resected PIK3CA-mutated colorectal cancer, per data from the ALASCCA trial.
View More
CheckMate 8HW: Nivolumab + Ipilimumab Shows Durable PFS Benefit in MSI-H/dMMR CRC
Michael Foote, MDColorectal Cancer | April 4, 2025
Dr. Michael Foote breaks down the CheckMate 8HW trial and supports dual immunotherapy as a first-line option in dMMR CRC.
View More
BREAKWATER Trial Signals New First-Line Option for BRAF V600E CRC
Michael Foote, MDColorectal Cancer | April 1, 2025
Dr. Foote discusses the BREAKWATER trial and the impact of BRAF-targeted therapy in metastatic colorectal cancer.
View More

  • 630 Madison Ave.

    Manalapan, NJ 07726

    • About Column

    About Us

    Editorial Policy

    Advertising


    Contribute Column

    eNewsletters

    Contribute

    Our Network

    GU Oncology Now

    Lung Cancers Today

    Cancer Nursing Today

    DocWire News

    MashupMD

    © 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.

    Terms of Use | Privacy Policy |